The UN has prioritized fighting antibiotic resistance. Meanwhile, the European Commission has granted 2.3 million Euros to Israeli biotech MeMed to help develop its fast blood test that distinguishes between bacterial and viral infections – and thus significantly reduces the unnecessary use of antibiotics. (See Aug 2015 newsletter)
Europe funds Israeli blood test for viruses and bacteria
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.